Harvard Medical School Instructor, Assistant, or Associate Professor
in the Computational Health Informatics Program
Boston Children’s Hospital
Boston, MA 

Establish your independent research program in computational health at Harvard and Boston Children’s Hospital.

CHIP, the Computational Health Informatics Program at Boston Children’s Hospital, an affiliate of Harvard Medical School and a collaborating program of its Department of Biomedical Informatics, is recruiting research faculty at junior and senior levels to join us in transforming care delivery and biomedical science.

We seek outstanding candidates passionate about advancing the ability to acquire and then reason over an entire spectrum of data types ranging from clinical, epidemiological, environmental, and social, all the way down to molecular and genomic.

Candidates who are expert in health IT architectures and standards (e.g., SMART on FHIR apps and infrastructure) will be given special consideration, as will faculty focused on transforming the point of care.

Areas of focus can include machine learning/AI including clinical decision support and predictive medicine, precision medicine, population health, real-world evidence and data visualization.

Candidates at the Instructor or Assistant Professor level should have strong quantitative backgrounds and a history of innovative approaches to biomedical scientific inquiry or the translation of computational methods to engineering or software applications in medicine. Candidates at the Associate Professor level must additionally demonstrate scientific leadership and the ability to develop sustainable, impactful projects.

All qualified applicants must have a doctoral degree (MD, PhD, MD/PhD, or equivalent) and a strong record of publishing. Faculty are expected to teach, be exceptional mentors and have or achieve substantial independent funding.

CHIP, founded in 1994, is a multidisciplinary applied research and education program. Biomedical informatics has become a major theme and methodology for biomedical science, health care delivery, and population health, involving high-dimensional modeling and understanding of patients from the molecular to the population levels. We design information infrastructure for medical decision making, diagnosis, care redesign, public health management, and re-imagined clinical trials. The field is inherently interdisciplinary, drawing on traditional biomedical disciplines, the science and technology of computing, data science, biostatistics, epidemiology, decision theory, omics, implementation science, and health care policy and management. Our faculty are trained in medicine, data science, computer science, mathematics and epidemiology. Though CHIP has a robust pediatric research agenda, our interests span across all ages. CHIP research highlights are here.

Boston Children’s Hospital is an equal opportunity employer that strongly encourages women and underrepresented minorities candidates apply for positions at our institution.

Interested applicants should submit a CV, cover letter, research plan, three references and three letters of support to Kenneth D. Mandl, MD, MPH, CHIP Director by emailing them to chip@childrens.harvard.edu. 

Applications may be considered on a rolling basis so there could be an advantage to submitting early.

Publications

Hopper RK, Abman SH, Elia EG, Avitabile CM, Yung D, Mullen MP, Austin ED, Bates A, Handler SS, Feinstein JA, Ivy DD, Kinsella JP, Mandl KD, Raj JU, Sleeper LA, . Pulmonary Hypertension in Children with Down Syndrome: Results from the Pediatric Pulmonary Hypertension Network Registry. The Journal of pediatrics 2022.

Wang X, Zhang HG, Xiong X, Hong C, Weber GM, Brat GA, Bonzel CL, Luo Y, Duan R, Palmer NP, Hutch MR, Gutiérrez-Sacristán A, Bellazzi R, Chiovato L, Cho K, Dagliati A, Estiri H, García-Barrio N, Griffier R, Hanauer DA, Ho YL, Holmes JH, Keller MS, Klann MEng JG, L'Yi S, Lozano-Zahonero S, Maidlow SE, Makoudjou A, Malovini A, Moal B, Moore JH, Morris M, Mowery DL, Murphy SN, Neuraz A, Yuan Ngiam K, Omenn GS, Patel LP, Pedrera-Jiménez M, Prunotto A, Jebathilagam Samayamuthu M, Sanz Vidorreta FJ, Schriver ER, Schubert P, Serrano-Balazote P, South AM, Tan ALM, Tan BWL, Tibollo V, Tippmann P, Visweswaran S, Xia Z, Yuan W, Zöller D, Kohane IS, Avillach P, Guo Z, Cai T, . SurvMaximin: Robust federated approach to transporting survival risk prediction models. Journal of biomedical informatics 2022.

Torous J, Stern AD, Bourgeois FT. Regulatory considerations to keep pace with innovation in digital health products. NPJ digital medicine 2022.

Levy S, Wisk LE, Minegishi M, Ertman B, Lunstead J, Brogna M, Weitzman ER. Association of Screening and Brief Intervention With Substance Use in Massachusetts Middle and High Schools. JAMA network open 2022.

Nielsen M, Presti M, Sztupinszki Z, Jensen AWP, Draghi A, Chamberlain CA, Schina A, Yde CW, Wojcik J, Szallasi Z, Crowther MD, Svane IM, Donia M. Co-existing alterations of MHC class I antigen presentation and IFNγ signaling mediate acquired resistance of melanoma to post-PD-1 immunotherapy. Cancer immunology research 2022.